Cargando…

The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations

More than 40% of non-small cell lung cancer (NSCLC) patients lack actionable targets and require non-targeted chemotherapeutics. Many become refractory to drugs due to underlying resistance-associated mutations. KEAP1 mutant NSCLCs further activate NRF2 and upregulate its client PTGR1. LP-184, a nov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulkarni, Aditya, McDermott, Joseph Ryan, Kathad, Umesh, Modali, Rama, Richard, Jean-Philippe, Sharma, Panna, Bhatia, Kishor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057270/ https://www.ncbi.nlm.nih.gov/pubmed/33889302 http://dx.doi.org/10.18632/oncotarget.27943

Ejemplares similares

A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications
por: Kathad, Umesh, et al.
Publicado: (2021)

SYST-12 LP-184, A NOVEL ACYLFULVENE-DERIVED TUMOR SITE ACTIVATED SMALL MOLECULE INHIBITS ADULT AND PEDIATRIC CNS TUMOR CELL GROWTH
por: Kulkarni, Aditya, et al.
Publicado: (2023)

LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair
por: Zhou, Jianli, et al.
Publicado: (2023)

Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair
por: Zhou, Jianli, et al.
Publicado: (2023)

Anticancer metallohelices: nanomolar potency and high selectivity
por: Kaner, Rebecca A., et al.
Publicado: (2016)

Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein
por: Cumaraswamy, Abbarna A., et al.
Publicado: (2014)

Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency
por: Guzelj, Samo, et al.
Publicado: (2022)

ATRT-05. DNA DAMAGE REPAIR INHIBITOR LP-184 INHIBITS CELL GROWTH IN ATRT
por: Kwon, Hyuk Jean, et al.
Publicado: (2023)

N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell lines
por: Vine, Kara L., et al.
Publicado: (2016)

Discovery of a new class of orthosteric antagonists with nanomolar potency at extrasynaptic GABA(A) receptors
por: Falk-Petersen, Christina Birkedahl, et al.
Publicado: (2020)

Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency
por: Zhang, Chun-Hui, et al.
Publicado: (2021)

Enantiodiscriminating Lipophilic Liquid Membrane-Based Assay for High-Throughput Nanomolar Enantioenrichment of Chiral Building Blocks
por: Jávor, Bálint, et al.
Publicado: (2023)

Anthocyanins Activate Membrane Estrogen Receptors With Nanomolar Potencies to Elicit a Nongenomic Vascular Response Via NO Production
por: Calfío, Camila, et al.
Publicado: (2021)

Peripheral T-cell lymphoma, not otherwise specified
por: Jha, Kunal Kishor, et al.
Publicado: (2017)

Nanomolar-potency ‘co-potentiator’ therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants
por: Phuan, Puay-Wah, et al.
Publicado: (2019)

Antimicrobial and Adjuvant Potencies of Di-n-alkyl Substituted Diazalariat Ethers
por: Patel, Mohit B., et al.
Publicado: (2023)

Nanomolar EP4 receptor potency and expression of eicosanoid-related enzymes in normal appearing colonic mucosa from patients with colorectal neoplasia
por: Feddersen, Ulrike Ries, et al.
Publicado: (2022)

Deformation change between $^{184m}$Au and $^{184g}$Au
por: Roussière, B, et al.
Publicado: (1998)

Correction: Nanomolar EP4 receptor potency and expression of eicosanoid-related enzymes in normal appearing colonic mucosa from patients with colorectal neoplasia
por: Feddersen, Ulrike Ries, et al.
Publicado: (2022)

In Sections or Otherwise
por: Patterson, J. D.
Publicado: (1904)

Electrochemical investigations of DNA-Intercalation potency of bisnitrophenoxy compounds with different alkyl chain lengths
por: Shakeel, Maria, et al.
Publicado: (2020)

Baryogenesis: electroweak and otherwise
por: Dine, Michael
Publicado: (1994)

Books, Good and Otherwise
Publicado: (1886)

Books, Good and Otherwise
Publicado: (1887)

Speeches, Wise and Otherwise
Publicado: (1903)

Superstitions, Medical and Otherwise
Publicado: (1904)

Benefits—Dental and Otherwise
por: Barker, C. C.
Publicado: (1888)

Nanomolar Inhibitors of Trypanosoma brucei RNA Triphosphatase
por: Smith, Paul, et al.
Publicado: (2016)

184th Session of the Council
por: Bennett, Sophia Elizabeth
Publicado: (2017)

Memorandum: PS184 experiment
por: Garreta, D
Publicado: (1982)

Transitions électromagnétiques observées dans les désintegrations du mercure-184 et du platine-184
por: Caillau, M, et al.
Publicado: (1973)

Determination of nuclear moments of $^{184g,184m}$Au using high resolution RIS at ISOLDE
por: Pinard, J, et al.
Publicado: (1997)

Inhibition of JK184-Induced Cytoprotective Autophagy Potentiates JK184 Antitumor Effects in Breast Cancer
por: Xi, Xiaoya, et al.
Publicado: (2020)

Activity of Xenoestrogens at Nanomolar Concentrations in the E-Screen Assay
por: Silva, Elisabete, et al.
Publicado: (2007)

Identification of Nanomolar Lectin Ligands by a Glycodendrimer Microarray
por: Laigre, Eugénie, et al.
Publicado: (2018)

Pulse dipolar EPR for determining nanomolar binding affinities
por: Ackermann, Katrin, et al.
Publicado: (2022)

Discovery of Nanomolar DCAF1 Small Molecule Ligands
por: Li, Alice Shi Ming, et al.
Publicado: (2023)

Pyrenebutyrate Pt(IV) Complexes with Nanomolar Anticancer Activity
por: Ahmedova, Anife, et al.
Publicado: (2023)

Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes Mellitus
por: Kostner, Karam M., et al.
Publicado: (2022)

Diarrhea in the Otherwise Healthy Infant
por: Brackett, Arthur S.
Publicado: (1950)

Cannot write session to /tmp/vufind_sessions/sess_mjrpisli1bu6mrtvu36emariou